Literature DB >> 3492791

Antihypertensive effect of neonatal thymectomy in the genetically hypertensive LH rat.

A Bataillard, J C Freiche, M Vincent, J Sassard, J L Touraine.   

Abstract

Genetically hypertensive (LH), normotensive (LN), and low blood pressure (LL) rats of the Lyon strains have been simultaneously selected according to their systolic blood pressure (SBP). SBP and immunological parameters were investigated in 5 week-old rats. SBP reached 99 +/- 2 mmHg in LL, 108 +/- 2 mmHg in LN and 122 +/- 4 mmHg in LH. White blood cell and lymphocyte counts, thymus and spleen histology, percentages of T cells and subsets of T cells in these organs were not modified by genetic hypertension. The blastogenic responses to mitogens (Con A and PWM) of the LH rat thymocytes were similar to those observed in LN or LL rats. By contrast, the proliferative response of splenocytes to PWM was positively correlated (r = 0.93) with SBP level. In additional experiments we demonstrated that, besides the immune defect induced by neonatal thymectomy, the removal of the thymus at birth prevented the spontaneous increase of SBP in LH strains (102 +/- 2 mmHg instead of 122 +/- 4 mmHg), while only a slight decrease or no alteration was seen in LN and LL thymectomized rats. This antihypertensive effect tended to maintain SBP at a common level in the 3 strains. These results suggest that the thymus may be involved in the development of genetic hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492791

Source DB:  PubMed          Journal:  Thymus        ISSN: 0165-6090


  16 in total

Review 1.  CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.

Authors:  Modar Kassan; Andrea Wecker; Philip Kadowitz; Mohamed Trebak; Khalid Matrougui
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

Review 2.  Dual opposing roles of adaptive immunity in hypertension.

Authors:  Noureddine Idris-Khodja; Muhammad Oneeb Rehman Mian; Pierre Paradis; Ernesto L Schiffrin
Journal:  Eur Heart J       Date:  2014-03-30       Impact factor: 29.983

Review 3.  Dysregulation of T cell subsets in the pathogenesis of hypertension.

Authors:  Songcang Chen; Devendra K Agrawal
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

4.  Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Erika I Boesen; Douglas L Williams; Jennifer S Pollock; David M Pollock
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-10       Impact factor: 2.557

5.  Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.

Authors:  Erin B Taylor; Jennifer M Sasser; Kenji J Maeda; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

6.  Splenocyte transfer exacerbates salt-sensitive hypertension in rats.

Authors:  Daniel J Fehrenbach; John Henry Dasinger; Hayley Lund; Jeylan Zemaj; David L Mattson
Journal:  Exp Physiol       Date:  2020-03-17       Impact factor: 2.969

7.  The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases.

Authors:  Jiandong Zhang; Steven D Crowley
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 8.  A new paradigm of sodium regulation in inflammation and hypertension.

Authors:  Annet Kirabo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-20       Impact factor: 3.619

Review 9.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 10.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.